Literature DB >> 4559150

A new therapeutic approach to Candida infections. A preliminary report.

G Medoff, W E Dismukes, R H Meade, J M Moses.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4559150

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  16 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  Enhancement of macrophage superoxide anion production by amphotericin B.

Authors:  E Wilson; L Thorson; D P Speert
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Authors:  V Petraitis; R Petraitiene; A H Groll; T Sein; R L Schaufele; C A Lyman; A Francesconi; J Bacher; S C Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 4.  Fungal endocarditis: patients at risk and their treatment.

Authors:  M S Seelig; P J Kozinin; P Goldberg; A R Berger
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

5.  Editorial: Chronic mucocutaneous candidiasis.

Authors: 
Journal:  Br Med J       Date:  1973-12-01

Review 6.  Management of laryngeal candidiasis: an evidence-based approach for the otolaryngologist.

Authors:  Pedro Valente; Joana Ferreira; Isabel Pinto; Nuno Medeiros; Pedro Oliveira; Eugénia Castro; Artur Condé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-27       Impact factor: 2.503

7.  Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.

Authors:  A S Bayer; J E Edwards; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.

Authors:  D L Oblack; W L Hewitt; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 9.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.